RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced that on Sept. 9 and 10 the Food and Drug Administration (FDA) performed an inspection of the company's Alachua, Fla. facility to verify effective implementation of the corrective actions taken after the company received a warning letter in October 2012. Upon completion of the inspection, inspectors noted the adequacy and effectiveness of the voluntary corrective actions and acknowledged the significant improvement in RTI's overall environmental monitoring program. All items in the warning letter were closed, and no new items, issues or FDA 483 observations were issued as part of this inspection.
On Oct. 23, 2012 the company received a warning letter from the FDA related to environmental monitoring activities in certain areas of its Alachua, Fla. processing facility. In response to the FDA’s observations, the company implemented a series of voluntary corrective actions to improve the overall environmental monitoring within the facility. The corrective actions were implemented in mid to late 2012. The FDA found these actions to be adequate during its two-day inspection, and the company expects a close-out letter to be issued.
“The outcome of this inspection confirms that we have taken the necessary steps to significantly improve our environmental monitoring program,” said Brian K. Hutchison, president and CEO. “We hold ourselves to a higher standard because of the importance of the work we do for the medical community and on behalf of the donation community. We are committed to ensuring that we have the most robust environmental monitoring and quality control procedures in our industry to maintain our status as the industry leader in patient safety.”
The October 2012 warning letter did not restrict the company’s ability to process or distribute implants, nor did it require the withdrawal of any implants from the marketplace. The issues noted in the warning letter did not impact patient safety.
About RTI Surgical Inc.
RTI is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to advancing science, safety and innovation, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.
RTI Surgical Inc.
Jenny Highlander, APR, 386-418-8888
Manager, Corporate Communications
|RTI Surgical Announces Successful Resolution to FDA Warning Letter for Alachua, Fla. Facility ()|
|RTI Surgical Announces 2013 Second Quarter Results (2013/8/6)|
|RTI Surgical™ Announces 2013 Third Quarter Results (2013/10/29)|
|RTI Surgical™ Announces 2013 Fourth Quarter, Full Year Results, 2014 Financial Guidance (2014/2/13)|
|RTI Surgical® Announces Renewal of Supply and Distribution Agreement with Zimmer, Inc. for Its Trauma Business (2014/2/19)|
|RTI Surgical™ Announces Launch of Tritium™ Sternal Cable Plating System ()|
|RTI Surgical™ Announces Preliminary Third Quarter 2013 Revenues (2013/10/16)|
|RTI Surgical™ Announces Agreement to Supply Complete Surgical Specialties Portfolio to Yankee Alliance Members (2014/1/13)|
|RTI Surgical™ Announces Launch of Two New Spine Systems: Aspect ® Anterior Cervical Plate System and MaxFuse™ VBR System (2014/2/24)|
|RTI Surgical™ Announces First Implantation of map3™ Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure (2013/9/25)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.